WeVote
Log In

Bill

Bill

SF 3473

Residual amounts of controlled substances contained in drug paraphernalia and similar items possession decriminalization

2025-2026 Regular Session Introduced by Clare Oumou Verbeten

Minnesota bill would decriminalize possession of drug paraphernalia containing trace controlled substances, reducing criminal penalties for this offense.

Referred to Judiciary and Public Safety
#drugsandmedicine #publicsafetyandpublicsafetydepartment
0
WeVote Research Nonpartisan
Bill Summary · SF 3473

Legislative bill overview

SF 3473 would decriminalize the possession of drug paraphernalia and similar items that contain residual amounts of controlled substances in Minnesota. Currently, possessing such items can result in criminal charges; this bill would remove or reduce criminal penalties for this specific offense. The bill was introduced in early May 2025 and is under review by the Judiciary and Public Safety Committee.

Why is this important

This legislation directly affects how the criminal justice system treats individuals found with drug paraphernalia containing trace amounts of drugs—a common scenario in drug enforcement. The change could reduce criminal records for thousands of people, potentially affecting employment, housing, and educational opportunities, while also shifting enforcement priorities and reducing court caseloads. It reflects broader policy debates about harm reduction versus traditional drug enforcement approaches.

Potential points of contention

  • Public safety concerns: Opponents may argue that decriminalization could normalize drug use or send a weak-on-drugs message, particularly in communities affected by opioid crises
  • Enforcement clarity: Questions about how law enforcement distinguishes between "residual amounts" and intentional possession, and whether this creates enforcement inconsistencies
  • Equity vs. unintended consequences: Supporters view this as criminal justice reform addressing disparate enforcement, while critics may worry about resource allocation or enabling drug dependency without treatment pathways

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.